OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
506001$1.4754

Wanjia Science Tech Innov Board 2Y Rgr Opn Mx Fd

Closed End FundsVerified

The fund has 110,282,100 basic and diluted shares outstanding, with a market price of $1.466 per share, resulting in a market capitalization of $161,673,558.60. No liquidity metrics are available due to missing balance-sheet inputs and lack of going-concern language in source documents. The fund's capital structure is not further disclosed, and no profitability or return metrics are available for comparison to industry benchmarks. No segment or geographic revenue breakdown is provided in the available data. Growth trajectory cannot be assessed due to the absence of historical revenue data or forward-looking guidance. Risk assessment indicates low dilution potential, but liquidity risk remains unassessed. No recent filings or transcripts are available to inform operational developments.

30-day price · 506001+0.43 (+36.5%)
Low$1.15High$1.68Close$1.62As of15 May, 00:00 UTC
Profile
CompanyWanjia Science Tech Innov Board 2Y Rgr Opn Mx Fd
Ticker506001.SS
SectorFinancials
BusinessCollective Investments
Industry groupCollective Investments
IndustryClosed End Funds
AI analysis

Business. Wanjia Science Tech Innov Board 2Y Rgr Opn Mx Fd is a hybrid securities investment fund managed by Wanjia Asset Management Co Ltd, seeking long-term steady growth of fund assets through collective investment strategies.

Classification. The fund is classified under Financials > Collective Investments > Closed End Funds with 92% confidence based on verified market data.

The fund has 110,282,100 basic and diluted shares outstanding, with a market price of $1.466 per share, resulting in a market capitalization of $161,673,558.60. No liquidity metrics are available due to missing balance-sheet inputs and lack of going-concern language in source documents. The fund's capital structure is not further disclosed, and no profitability or return metrics are available for comparison to industry benchmarks. No segment or geographic revenue breakdown is provided in the available data. Growth trajectory cannot be assessed due to the absence of historical revenue data or forward-looking guidance. Risk assessment indicates low dilution potential, but liquidity risk remains unassessed. No recent filings or transcripts are available to inform operational developments.
Key takeaways
  • The fund has a market capitalization of $161.7 million with no disclosed liquidity metrics.
  • No profitability or return metrics are available for benchmarking.
  • Dilution risk is assessed as low, but liquidity risk remains unquantified.
  • No segment or geographic revenue data is disclosed in the available financials.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "Not available due to missing profitability data.",
  • "rd_outlook_rationale": "Not available due to missing R&D disclosure.",
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1.47
Market cap$161.7M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Closed End Funds · cohort 11 companies
Metric506001Activity
Op margin55.6% medp25 35.9% · p75 83.7%
Net margin54.5% medp25 -2.5% · p75 86.3%
Gross margin67.0% medp25 47.0% · p75 89.7%
CapEx / revenue-3.8% medp25 -7.7% · p75 -0.6%
Debt / equity7.0% medp25 0.0% · p75 77.9%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 23:42 UTC#623046bb
Market quoteclose USD 1.47 · shares 0.11B diluted
no public URL
2026-05-03 23:42 UTC#b07da51c
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 23:43 UTCJob: 1e8111a0